Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SEEK
HVIVO Seeks Big Pharma Partner For ‘Phase III-Ready’ Universal Flu Vaccine
Presenting Phase IIb data on FLU-v, specialized CRO hVIVO now hopes to secure a big pharma partner for Phase III studies and commercialization of the universal flu vaccine candidate. The product has been developed in a joint venture with SEEK.
Infirst Later Than Expected With Lipid-Format Ibuprofen, But On Time In Business Plan
The London firm announces Unicough cough/cold product’s launch after reviewing clinical trial results, but holds off on a Flarin ibuprofen launch until completing a trial. “We’re very, very pleased with this, although originally we wanted to be there slightly earlier,” says CEO Manfred Scheske.
Infirst Later Than Expected With Lipid-Format Ibuprofen, But On Time In Business Plan
The London firm announces Unicough cough/cold product’s launch after reviewing clinical trial results, but holds off on a Flarin ibuprofen launch until completing a trial. “We’re very, very pleased with this, although originally we wanted to be there slightly earlier,” says CEO Manfred Scheske.
Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents
CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Aventis,GlaxoSmithKline,and Pfizer